Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1996
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996WO1996013164A1 Polymeric wound healing accelerators
05/09/1996WO1996010034A3 Thiol-free inhibitors of farnesyl-protein transferase
05/09/1996DE4439477A1 Use of alpha-liponic acid, its isomers and derivs.
05/09/1996DE19540669A1 Non-parenteral interferon compsn.
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203659A1 Pyridopyrimidones, quinolines and fused n-heterocycles as bradykinin antagonists
05/09/1996CA2203257A1 Device for aerosolized delivery of peptide drugs
05/09/1996CA2202881A1 Stretch-activated cation channel and antisense oligonucleotides thereto
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996CA2200468A1 Muscarine antagonists
05/09/1996CA2200462A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
05/09/1996CA2162089A1 ¬3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy|-pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists
05/08/1996EP0710669A1 Novel protein having avidity with heparin-binding growth factor
05/08/1996EP0710665A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/08/1996EP0710662A1 Quinolinecarboxylic acid derivative
05/08/1996EP0710658A1 5-(Aryloxymethyl)oxazolines, process for their preparation and pharmaceutical compositions containing them
05/08/1996EP0710657A1 Antagonists of adhesion receptors
05/08/1996EP0710285A1 Analogues of an anti-thrombin polypeptide and process for their preparation
05/08/1996EP0710267A1 Storage stable partially neutralized acid compositions and uses
05/08/1996EP0710251A1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710233A1 Heteroaryl cycloalkenyl hydroxyureas
05/08/1996EP0710116A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
05/08/1996EP0710112A1 Use of vitamin D and derivatives thereof for the manufacture of a medicament for protection against neuron loss
05/08/1996EP0710109A1 Compounds
05/08/1996EP0667791A4 Isolation, growth, differentiation and genetic engineering of human muscle cells.
05/08/1996EP0585440B1 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
05/08/1996EP0580648B1 Process for conditioning of water-soluble substances
05/08/1996CN1122138A Foldback triplex-forming oligonucleotides
05/08/1996CN1122105A Treatment of tumors with compounds having RXR retinoid receptor agonist activity
05/08/1996CN1121921A New benzothiadiazine compound, process for its preparation and the pharmaceutical compositions which contain it
05/08/1996CN1121826A "Fukangling" medicine for treatment of gynecopathy
05/08/1996CN1121806A Pharmaceutical agents for treatment of emesis
05/07/1996US5514801 Cyclic sulfone containing retroviral protease inhibitors
05/07/1996US5514786 Compositions for inhibiting RNA activity
05/07/1996US5514778 Anti-picornaviral agents
05/07/1996US5514777 Methods of synthesis of peptidyl argininals
05/07/1996US5514718 Amino compounds with alkoxy, hydroxy, ketone or oxime groups for psychological disorders or tachykinin antagonist
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514702 Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514682 Fused imidazole and triazole derivatives as 5-HT1 receptor agonists
05/07/1996US5514677 Hydroxamic acid based collagenase inhibitors
05/07/1996US5514662 Hiv infections
05/07/1996CA2099565C N-hydroxyurea derivatives as antiallergy and antiinflammatory agents
05/07/1996CA2075551C Treatment of periodontitis
05/04/1996CA2159850A1 Phosphonosulfonate squalene synthetase inhibitor salts and method
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012800A1 Modified factor vii
05/02/1996WO1996012727A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer
05/02/1996WO1996012724A1 Novel quinoxalindione derivatives, their production and use in medicaments
05/02/1996WO1996012720A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
05/02/1996WO1996012715A1 Cyclopropachromenecarboxylate derivatives
05/02/1996WO1996012697A2 Calcium receptor-active compounds
05/02/1996WO1996012503A1 Remedy for diseases caused by il-6 production
05/02/1996WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes
05/02/1996WO1996012491A1 Method of inhibiting conditions associated with bradykinin
05/02/1996WO1996012490A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996WO1996012487A1 Combination method for acne treatment
05/02/1996WO1996012482A1 Hydroxyethyl aminimides
05/02/1996WO1996012480A1 Polyamine compounds for treating vascular proliferative disorders
05/02/1996WO1996012479A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996WO1996012415A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996DE4439492A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments
05/02/1996CA2203914A1 Method of inhibiting conditions associated with bradykinin
05/02/1996CA2203656A1 New quinoxalinedione derivatives, their production and use in pharmaceutical agents
05/02/1996CA2203280A1 Modified factor vii
05/02/1996CA2203271A1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs
05/02/1996CA2203123A1 Hydroxyethyl aminimides
05/02/1996CA2203106A1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
05/02/1996CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996CA2200990A1 Methods of inhibiting conditions associated with neuropeptide y
05/02/1996CA2199979A1 Combination method for acne treatment
05/02/1996CA2198914A1 Polyamine compounds for treating vascular proliferative disorders
05/01/1996EP0709384A1 Benzylpiperidine derivatives having high affinity for binding sites of aminoacid receptors
05/01/1996EP0709381A1 Heterocyclic compounds and their preparation and use
05/01/1996EP0709376A2 Therapeutic compounds
05/01/1996EP0709375A2 Therapeutic heterocycles
05/01/1996EP0709304A1 Package for a veterinary implant
05/01/1996EP0708773A1 Fused cycloalkylimidazopyridines
05/01/1996EP0708772A1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708765A1 Substituted piperazinylcamphor derivatives as oxytocin antagonists
05/01/1996EP0708763A1 Process for making hiv protease inhibitors
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors
05/01/1996EP0708653A1 Assay and reagents for identifying anti-proliferative agents
05/01/1996EP0708648A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
05/01/1996CN1121717A Heterocyclic compounds and their preparation and use
05/01/1996CN1121714A Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
05/01/1996CN1121710A Heterocyclic compounds, their use and preparation
05/01/1996CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D
05/01/1996CN1121688A Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
05/01/1996CN1121430A Inmunization adjusting, anti-inflamation agent
05/01/1996CN1031705C Process for preparing 24-homo-vitamin-D-derivatives
05/01/1996CA2161618A1 Benzylpiperidine derivatives
04/1996
04/30/1996US5512681 Angiotensin II receptor blocking imidazolinone derivatives
04/30/1996US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids
1 ... 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 ... 1564